Our results, taken together with those of Yao et al., clearly establish PRMT7 as a key mediator of breast cancer cell invasiveness and demonstrate that PRMT7 represents a novel biomarker and may be a promising new therapeutic target. Here, PRMT7 is linked to breast cancer.